glp-1 weight loss timeline of discovery and clinical development. (a) Key events in The Landscape Of GLP-1 Receptor
Description
RM-131 (100 g/day, subcutaneous) accelerated gastric emptying in patients with type 1 or 2 diabetes who had upper gastrointestinal symptoms
Continuous covariates (eg, age) were entered as main terms and quadratic terms
Table: Comparing the Major GLP-1 Receptor Agonist Drugs To summarize the key characteristics of the GLP-1 drugs up to this point (prior to semaglutide), the table below compares their properties: Table 2: Comparison of GLP-1based therapies
Fierce Healthcare
Understanding the Growing Interest in GLP-1 Medications Are you a breastfeeding mother wondering about taking weight loss medications like semaglutide (Ozempic, Wegovy, or Rybelsus) or tirzepatide (Mounjaro or Zepbound)
c Mammalian GLP-1: 3297.7
